Biotech · Private company
Vasgene Therapeutics, Inc
Track this companyFree. Adds Vasgene Therapeutics, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials72 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- CisplatinPhase 3 · Muscle-Invasive Bladder CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Enfortumab vedotinPhase 3 · Muscle-Invasive Bladder CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 3 · Muscle-Invasive Bladder CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 3 · Muscle-Invasive Bladder CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- SEphB4-HSAPhase 3 · Muscle-Invasive Bladder CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Pembrolizumab + sEphB4-HSAPhase 2 · Metastatic Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- sEphB4-HSAPhase 2 · Kaposi SarcomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- Modular Trial of sEphB4-HSA in EphrinB2-High Solid TumorsPHASE2_PHASE3 · RECRUITING · started Mar 15, 2025ClinicalTrials.gov NCT06493552 · fetched Nov 12, 2026
- A Study of sEphB4-HSA in Kaposi SarcomaPHASE2 · UNKNOWN · started Sep 17, 2020ClinicalTrials.gov NCT03993106 · fetched Nov 12, 2026
- A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial CarcinomaPHASE2 · UNKNOWN · started Aug 14, 2020ClinicalTrials.gov NCT04486781 · fetched Nov 12, 2026
- sEphB4-HSA With RT+Chemo or Cetux in Patients With Intermediate to High Risk LAHNSCCPHASE1 · COMPLETED · started Jan 6, 2020ClinicalTrials.gov NCT04091867 · fetched Nov 12, 2026
- sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate CancerPHASE2 · UNKNOWN · started Sep 20, 2019ClinicalTrials.gov NCT04033432 · fetched Nov 12, 2026
- Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Sep 3, 2015ClinicalTrials.gov NCT02495896 · fetched Nov 12, 2026
- Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid TumorsPHASE1 · TERMINATED · started Sep 6, 2012ClinicalTrials.gov NCT01642342 · fetched Nov 12, 2026